Report cover image

Global Acute Myeloid Leukemia Therapeutics Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18740240

Description

Global Acute Myeloid Leukemia Therapeutics Databank Market Report


The Acute Myeloid Leukemia Therapeutics market was valued at $8,798.5 Million in 2022, and is projected to reach $13,821.6 Million by 2031 growing at a CAGR of 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering a CAGR of 4.75%. Chemotherapy segment is anticipated to reach $4,883.0 Million by 2031 with the highest CAGR of 6.05%.

Table of Contents

100 Pages
1. Global Acute Myeloid Leukemia Therapeutics Market, By Drug Class
1.1. Overview
1.2. Chemotherapy
1.2.1 Chemotherapy Market, By Region
1.2.1.1 North America Chemotherapy Market, By Country
1.2.1.2 Europe Chemotherapy Market, By Country
1.2.1.3 Asia-Pacific Chemotherapy Market, By Country
1.2.1.4 Rest of World Chemotherapy Market, By Country
1.3. Targeted Therapy and Immunotherapy
1.3.1 Targeted Therapy and Immunotherapy Market, By Region
1.3.1.1 North America Targeted Therapy and Immunotherapy Market, By Country
1.3.1.2 Europe Targeted Therapy and Immunotherapy Market, By Country
1.3.1.3 Asia-Pacific Targeted Therapy and Immunotherapy Market, By Country
1.3.1.4 Rest of World Targeted Therapy and Immunotherapy Market, By Country
2. Global Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
2.1. Overview
2.2. Hospital Pharmacies
2.2.1 Hospital Pharmacies Market, By Region
2.2.1.1 North America Hospital Pharmacies Market, By Country
2.2.1.2 Europe Hospital Pharmacies Market, By Country
2.2.1.3 Asia-Pacific Hospital Pharmacies Market, By Country
2.2.1.4 Rest of World Hospital Pharmacies Market, By Country
2.3. Drug Stores and Retail Pharmacies
2.3.1 Drug Stores and Retail Pharmacies Market, By Region
2.3.1.1 North America Drug Stores and Retail Pharmacies Market, By Country
2.3.1.2 Europe Drug Stores and Retail Pharmacies Market, By Country
2.3.1.3 Asia-Pacific Drug Stores and Retail Pharmacies Market, By Country
2.3.1.4 Rest of World Drug Stores and Retail Pharmacies Market, By Country
2.4. Online Provides
2.4.1 Online Provides Market, By Region
2.4.1.1 North America Online Provides Market, By Country
2.4.1.2 Europe Online Provides Market, By Country
2.4.1.3 Asia-Pacific Online Provides Market, By Country
2.4.1.4 Rest of World Online Provides Market, By Country
3. Global Acute Myeloid Leukemia Therapeutics Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.2.2 North America Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.2.3 North America Acute Myeloid Leukemia Therapeutics Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.2.3.1.2 U.S. Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.2.3.2 Canada
3.2.3.2.1 Canada Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.2.3.2.2 Canada Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.3. Europe
3.3.1 Europe Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.3.2 Europe Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.3.3 Europe Acute Myeloid Leukemia Therapeutics Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.3.3.1.2 Germany Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.3.3.2 U.K.
3.3.3.2.1 U.K. Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.3.3.2.2 U.K. Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.3.3.3 France
3.3.3.3.1 France Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.3.3.3.2 France Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.3.3.4 Italy
3.3.3.4.1 Italy Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.3.3.4.2 Italy Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.3.3.5 Spain
3.3.3.5.1 Spain Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.3.3.5.2 Spain Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.3.3.6.2 Rest of Europe Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.4. Asia-Pacific
3.4.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.4.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.4.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market, By Country
3.4.3.1 China
3.4.3.1.1 China Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.4.3.1.2 China Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.4.3.2 Japan
3.4.3.2.1 Japan Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.4.3.2.2 Japan Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.4.3.3 South Korea
3.4.3.3.1 South Korea Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.4.3.3.2 South Korea Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.4.3.4 India
3.4.3.4.1 India Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.4.3.4.2 India Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.4.3.5 Indonesia
3.4.3.5.1 Indonesia Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.4.3.5.2 Indonesia Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.4.3.6.2 Rest of Asia Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.5. Rest of World
3.5.1 Rest of World Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.5.2 Rest of World Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.5.3 Rest of World Acute Myeloid Leukemia Therapeutics Market, By Country
3.5.3.1 Brazil
3.5.3.1.1 Brazil Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.5.3.1.2 Brazil Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.5.3.2 Mexico
3.5.3.2.1 Mexico Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.5.3.2.2 Mexico Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.5.3.3 South Africa
3.5.3.3.1 South Africa Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.5.3.3.2 South Africa Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.5.3.4 Australia
3.5.3.4.1 Australia Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.5.3.4.2 Australia Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
3.5.3.5 RoW Countries
3.5.3.5.1 RoW Countries Acute Myeloid Leukemia Therapeutics Market, By Drug Class
3.5.3.5.2 RoW Countries Acute Myeloid Leukemia Therapeutics Market, By Distribution Channel
RoW Countries Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 2. Chemotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 7. Targeted Therapy and Immunotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Targeted Therapy and Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Targeted Therapy and Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Targeted Therapy and Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Targeted Therapy and Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 12. Global Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 13. Hospital Pharmacies Market Value, By Region, 2022-2031, Million USD
TABLE 14. North America Hospital Pharmacies Market Value, By Country, 2022-2031, Million USD
TABLE 15. Europe Hospital Pharmacies Market Value, By Country, 2022-2031, Million USD
TABLE 16. Asia-Pacific Hospital Pharmacies Market Value, By Country, 2022-2031, Million USD
TABLE 17. Rest of World Hospital Pharmacies Market Value, By Country, 2022-2031, Million USD
TABLE 18. Drug Stores and Retail Pharmacies Market Value, By Region, 2022-2031, Million USD
TABLE 19. North America Drug Stores and Retail Pharmacies Market Value, By Country, 2022-2031, Million USD
TABLE 20. Europe Drug Stores and Retail Pharmacies Market Value, By Country, 2022-2031, Million USD
TABLE 21. Asia-Pacific Drug Stores and Retail Pharmacies Market Value, By Country, 2022-2031, Million USD
TABLE 22. Rest of World Drug Stores and Retail Pharmacies Market Value, By Country, 2022-2031, Million USD
TABLE 23. Online Provides Market Value, By Region, 2022-2031, Million USD
TABLE 24. North America Online Provides Market Value, By Country, 2022-2031, Million USD
TABLE 25. Europe Online Provides Market Value, By Country, 2022-2031, Million USD
TABLE 26. Asia-Pacific Online Provides Market Value, By Country, 2022-2031, Million USD
TABLE 27. Rest of World Online Provides Market Value, By Country, 2022-2031, Million USD
TABLE 28. Global Acute Myeloid Leukemia Therapeutics Market Value, By Region, 2022-2031, Million USD
TABLE 29. North America Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 30. North America Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 31. North America Acute Myeloid Leukemia Therapeutics Market Value, By Country, 2022-2031, Million USD
TABLE 32. U.S. Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 33. U.S. Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 34. Canada Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 35. Canada Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 36. Europe Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 37. Europe Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 38. Europe Acute Myeloid Leukemia Therapeutics Market Value, By Country, 2022-2031, Million USD
TABLE 39. Germany Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 40. Germany Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 41. U.K. Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 42. U.K. Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 43. France Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 44. France Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 45. Italy Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 46. Italy Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 47. Spain Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 48. Spain Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 49. Rest of Europe Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 50. Rest of Europe Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 51. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 52. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 53. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Value, By Country, 2022-2031, Million USD
TABLE 54. China Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 55. China Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 56. Japan Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 57. Japan Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 58. South Korea Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 59. South Korea Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 60. India Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 61. India Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 62. Indonesia Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 63. Indonesia Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 64. Rest of Asia Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 65. Rest of Asia Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 66. Rest of World Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 67. Rest of World Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 68. Rest of World Acute Myeloid Leukemia Therapeutics Market Value, By Country, 2022-2031, Million USD
TABLE 69. Brazil Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 70. Brazil Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 71. Mexico Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 72. Mexico Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 73. South Africa Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 74. South Africa Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 75. Australia Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 76. Australia Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
TABLE 77. RoW Countries Acute Myeloid Leukemia Therapeutics Market Value, By Drug Class, 2022-2031, Million USD
TABLE 78. RoW Countries Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD
RoW Countries Acute Myeloid Leukemia Therapeutics Market Value, By Distribution Channel, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us